Compare M&T Bank Corporation (MTB) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
M&T Bank Corporation vs Zoetis Inc — how do they compare? M&T Bank Corporation trades at $217.33 (market cap $31.42B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: M&T Bank Corporation and Zoetis Inc are close in size by market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold M&T Bank Corporation for 100 Days and Zoetis Inc for 70 Days on average.
| MTB | ZTS | |
|---|---|---|
Market Cap | $31.42B | $30.20B |
Volume | 1,438,219 | 6,175,327 |
Sector | Financials | Health |
52-Week High | $254.09 | $147.53 |
52-Week Low | $178.63 | $69.09 |
Typical Hold Time | 100 Days | 70 Days |
Enterprise Value | $47.77B | $37.76B |
Dividend Yield | 2.76% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
M&T Bank Corporation (MTB) trades at $217.23, up 0.29% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with P/E of 11.52, net margin of 30.85%, and consistent dividend payments. Recent news highlights branch expansion and AI investments driving loan growth, while analyst consensus remains cautiously optimistic with a $258.92 price target.
MTB presents a compelling value opportunity with attractive valuation metrics and solid profitability, though technical indicators suggest near-term pressure. The bank's strategic investments in technology and expanding fee businesses support long-term growth, but investors should monitor interest rate sensitivity and competitive banking sector dynamics.
Zoetis (ZTS) trades at $74.38, up 3.96% in the last session, with a bullish technical signal and strong profitability metrics including a 71.67% gross margin and 27.69% net income margin. Recent earnings show mixed results, with a beat in Q2 2026 but a miss in Q1 2026, while Q3 2026 results are pending. The company maintains robust cash flow from operations of $2.90B in 2025 and a solid balance sheet with $1.99B in cash. Analyst consensus is a Buy with a $87.33 price target, though sentiment is tempered by near-term competitive pressures.
The outlook for ZTS is cautiously optimistic, supported by industry-leading margins and a diversified product portfolio, but faces headwinds from U.S. companion animal market weakness and increased competition. Investment opportunity lies in its undervalued P/E of 11.92 relative to growth potential, while risks include pricing erosion and volume declines. The stock's current level near resistance at $74 suggests potential for consolidation before further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
